Perceptive Advisors LLC Athira Pharma, Inc. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 5,402,964 shares of ATHA stock, worth $1.89 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,402,964
Previous 5,402,964
-0.0%
Holding current value
$1.89 Million
Previous $2.43 Million
31.1%
% of portfolio
0.11%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding ATHA
# of Institutions
62Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Bml Capital Management, LLC Zionsville, IN2.78MShares$971,5591.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$544,8270.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$522,4770.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$522,4770.87% of portfolio
-
Black Rock Inc. New York, NY676KShares$236,6850.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $13.2M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...